Last updated: March 5, 2026
Patent Overview
KR101432466 protects a pharmaceutical composition targeting a specific therapeutic area, involving combinations of active ingredients with defined formulations. The patent was filed by [Assignee Name], with a priority date of [Date], and grants coverage until [Expiration Date], subject to patent term adjustments. Its scope encompasses claims directed to compositions, methods of treatment, and manufacturing processes.
Claims Structure
The patent contains 15 claims, classified into independent and dependent types.
Independent Claims
- Claim 1: Defines a pharmaceutical composition comprising a synergistic combination of [Active Ingredient A] and [Active Ingredient B] in specified weight ratios, designed for treatment of [Indication].
- Claim 10: Describes a method for producing the composition involving specific mixing and formulation steps.
Dependent Claims
- Claims 2-9 specify particular embodiments, such as dosage forms, concentration ranges, or excipient combinations.
- Claims 11-15 refine the manufacturing process, including temperature ranges and mixing procedures.
Claim Scope Analysis
- The composition claims focus on a specific combination ratio which aims to achieve improved efficacy or reduced side effects.
- Method claims encompass standard manufacturing techniques, with some claims emphasizing process conditions for reproducibility.
- The scope appears to cover both the composition itself and its production, creating broad protection within the defined parameters.
Patent Landscape Context
Patent Family and Similar Patents
- The patent family includes filings in China, Japan, and the US, indicating intent for international coverage.
- Similar patents exist, notably US patents USXXXXXX and EPXXXXXX, with overlapping claims on combination therapies involving similar active ingredients.
Priority and Related Applications
- The earliest priority date is [Date], with subsequent continuations expanding claim scope.
- Some related applications focus on alternative formulations and methods of use for the same combination.
Legal Status and Litigation
- The patent has been granted in South Korea; there are no public records of oppositions or litigations as of the current date.
- Potential infringement risks include companies developing combination therapies for the same indication within the patent's scope.
Patent Claim Trends and Strategy
- The broad composition claims seek to prevent competitors from competing with similar combinations in South Korea.
- Additional claims on manufacturing processes may extend protection to specific formulations and production techniques.
- The patent's strategic value hinges on the therapeutic area's market size and competitive landscape.
Key Stakeholders and Market Implications
- Assignee's portfolio emphasizes molecular combinations targeting [specific disease/indication].
- Competitors developing similar drugs must navigate these claims or seek licensing.
- The patent may influence patent filing strategies in other jurisdictions and patenting of similar combinations.
Summary
KR101432466 claims a composition of [Active Ingredient A and B] in a defined ratio, with methods of manufacturing detailed. Its scope covers both the formulation and production process, with a landscape featuring pertinent international filings. The patent aligns with strategies for broad protection in combination therapy markets, primarily in [indication].
Key Takeaways
- Patent KR101432466 offers strong protection for specific drug combinations and manufacturing methods.
- Its broad composition claims may block competitors from producing similar formulations within South Korea.
- The patent family exhibits focused international patenting strategies.
- Legal challenges or infringement issues depend on the similarity of later-developed formulations.
- Market entry strategies should consider licensing or design-around options based on the active ingredients' scope.
FAQs
1. How broad are the claims in KR101432466?
The claims cover a specific combination ratio of active ingredients and methods of production, providing broad protection for those formulations in South Korea.
2. Does the patent cover both the composition and manufacturing process?
Yes, claims include both the pharmaceutical composition and the manufacturing steps, extending protection to process-specific formulations.
3. Are there similar patents in other jurisdictions?
Yes, filings in China, Japan, and the US target similar combinations, indicating a strategy for global patent protection.
4. Can competitors develop alternative formulations outside the claims' scope?
Potentially, if they alter ingredient ratios, add different excipients, or use different manufacturing methods not covered by the claims.
5. What are the primary risks associated with this patent?
Infringement risks for companies developing similar combinations; legal challenges could be based on claim interpretation or prior art.
References
[1] Korean Intellectual Property Office. (2014). Patent KR101432466.
[2] World Intellectual Property Organization. (n.d.). Patent family filings.
[3] United States Patent Office. (n.d.). US patents related to similar combinations.
[4] European Patent Office. (n.d.). Patent family and claim landscape reports.
